S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   311.76 (-0.34%)
AAPL   121.81 (+0.68%)
MSFT   229.98 (+0.43%)
FB   257.20 (+0.99%)
GOOGL   2,007.10 (-0.44%)
AMZN   3,044.65 (-0.41%)
TSLA   664.86 (-2.54%)
NVDA   535.79 (+0.66%)
BABA   238.90 (-0.53%)
CGC   32.47 (-2.23%)
GE   12.49 (-2.12%)
MU   88.63 (+0.58%)
NIO   45.06 (-3.74%)
AMD   83.28 (+1.04%)
T   28.41 (-0.77%)
F   11.60 (-1.36%)
ACB   10.71 (-1.02%)
DIS   186.10 (-2.56%)
BA   212.06 (-2.03%)
NFLX   538.61 (-1.48%)
BAC   34.85 (-3.01%)
S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   311.76 (-0.34%)
AAPL   121.81 (+0.68%)
MSFT   229.98 (+0.43%)
FB   257.20 (+0.99%)
GOOGL   2,007.10 (-0.44%)
AMZN   3,044.65 (-0.41%)
TSLA   664.86 (-2.54%)
NVDA   535.79 (+0.66%)
BABA   238.90 (-0.53%)
CGC   32.47 (-2.23%)
GE   12.49 (-2.12%)
MU   88.63 (+0.58%)
NIO   45.06 (-3.74%)
AMD   83.28 (+1.04%)
T   28.41 (-0.77%)
F   11.60 (-1.36%)
ACB   10.71 (-1.02%)
DIS   186.10 (-2.56%)
BA   212.06 (-2.03%)
NFLX   538.61 (-1.48%)
BAC   34.85 (-3.01%)
S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   311.76 (-0.34%)
AAPL   121.81 (+0.68%)
MSFT   229.98 (+0.43%)
FB   257.20 (+0.99%)
GOOGL   2,007.10 (-0.44%)
AMZN   3,044.65 (-0.41%)
TSLA   664.86 (-2.54%)
NVDA   535.79 (+0.66%)
BABA   238.90 (-0.53%)
CGC   32.47 (-2.23%)
GE   12.49 (-2.12%)
MU   88.63 (+0.58%)
NIO   45.06 (-3.74%)
AMD   83.28 (+1.04%)
T   28.41 (-0.77%)
F   11.60 (-1.36%)
ACB   10.71 (-1.02%)
DIS   186.10 (-2.56%)
BA   212.06 (-2.03%)
NFLX   538.61 (-1.48%)
BAC   34.85 (-3.01%)
S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   311.76 (-0.34%)
AAPL   121.81 (+0.68%)
MSFT   229.98 (+0.43%)
FB   257.20 (+0.99%)
GOOGL   2,007.10 (-0.44%)
AMZN   3,044.65 (-0.41%)
TSLA   664.86 (-2.54%)
NVDA   535.79 (+0.66%)
BABA   238.90 (-0.53%)
CGC   32.47 (-2.23%)
GE   12.49 (-2.12%)
MU   88.63 (+0.58%)
NIO   45.06 (-3.74%)
AMD   83.28 (+1.04%)
T   28.41 (-0.77%)
F   11.60 (-1.36%)
ACB   10.71 (-1.02%)
DIS   186.10 (-2.56%)
BA   212.06 (-2.03%)
NFLX   538.61 (-1.48%)
BAC   34.85 (-3.01%)
Log in
OTCMKTS:SSMXY

Sysmex Stock Forecast, Price & News

$54.09
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$51.91
Now: $54.09▼
$55.26
50-Day Range
$54.09
MA: $59.63▼
$63.95
52-Week Range
$26.29
Now: $54.09▼
$65.49
Volume20,083 shs
Average Volume20,027 shs
Market Capitalization$22.58 billion
P/E Ratio81.95
Dividend Yield0.46%
Beta0.24
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Headlines

F. Hoffmann-La Roche Ltd: Roche renews partnership with Sysmex to deliver haematology testing solutions
January 25, 2021 |  finanznachrichten.de
Sysmex America to Distribute FDA Cleared CellaVision® DC-1 for Low-Volume Hematology Labs
November 17, 2020 |  prnewswire.com
Sysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management
September 8, 2020 |  prnewswire.com
Sysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS Testing
August 5, 2020 |  finance.yahoo.com
Sysmex America Releases Caresphere™ Workflow Solution (WS) Designed to Deliver Efficiency Increases to Labs
August 3, 2020 |  www.prnewswire.com
Sysmex America Launches XF-1600™: New Automated Flow Cytometer Provides Improved Flexibility and Efficiency
June 17, 2020 |  finance.yahoo.com
De Novo Software: Sysmex Partec Will Bundle FCS Express 7 Flow With the CyFlow Cube 6
May 25, 2020 |  www.finanznachrichten.de
Sysmex Corp. ADR
April 25, 2020 |  www.barrons.com
Sysmex Inostics' Updated SafeSEQ Breast Cancer Panel Advances Novel Clinical Uses of ctDNA Through Quantitative Testing
March 9, 2020 |  www.prnewswire.com
Sysmex 2020: Performance, Capabilities, Goals & Strategies in the Global Diagnostics Industry - ResearchAndMarkets.com
February 6, 2020 |  www.businesswire.com
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood
December 8, 2019 |  www.benzinga.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SSMXY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.sysmex.co.jp
Phone817-8265-0500
Employees8,200
Year Founded1968

Debt

Debt-to-Equity Ratio0.06
Current Ratio2.86
Quick Ratio2.13

Price-To-Earnings

Trailing P/E Ratio81.95
Forward P/E Ratio38.91
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.78 billion
Price / Sales8.13
Cash Flow$1.13 per share
Price / Cash Flow47.66
Book Value$6.13 per share
Price / Book8.82

Profitability

EPS (Most Recent Fiscal Year)$0.77
Net Income$320.91 million
Net Margins10.29%
Return on Equity10.73%
Return on Assets7.91%

Miscellaneous

Outstanding Shares417,417,000
Market Cap$22.58 billion
Next Earnings Date3/3/2021 (Estimated)
OptionableNot Optionable

MarketRank™

Overall MarketRank™

0.57 out of 5 stars

Medical Sector

1379th out of 1,957 stocks

Private Households Industry

267th out of 376 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$54.09
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SSMXY News and Ratings via Email

Sign-up to receive the latest news and ratings for SSMXY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sysmex (OTCMKTS:SSMXY) Frequently Asked Questions

Is Sysmex a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sysmex in the last twelve months. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Sysmex stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SSMXY, but not buy additional shares or sell existing shares.
View analyst ratings for Sysmex or view top-rated stocks.

What stocks does MarketBeat like better than Sysmex?

Wall Street analysts have given Sysmex a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sysmex wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sysmex?

Sysmex saw a decrease in short interest in January. As of January 29th, there was short interest totaling 5,700 shares, a decrease of 52.9% from the January 14th total of 12,100 shares. Based on an average trading volume of 30,000 shares, the short-interest ratio is presently 0.2 days.
View Sysmex's Short Interest.

When is Sysmex's next earnings date?

Sysmex is scheduled to release its next quarterly earnings announcement on Wednesday, March 3rd 2021.
View our earnings forecast for Sysmex.

How has Sysmex's stock been impacted by COVID-19?

Sysmex's stock was trading at $30.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SSMXY shares have increased by 76.6% and is now trading at $54.09.
View which stocks have been most impacted by COVID-19.

Is Sysmex a good dividend stock?

Sysmex pays an annual dividend of $0.25 per share and currently has a dividend yield of 0.46%. The dividend payout ratio of Sysmex is 32.47%. This payout ratio is at a healthy, sustainable level, below 75%.
View Sysmex's dividend history.

What guidance has Sysmex issued on next quarter's earnings?

Sysmex issued an update on its FY 2021 Pre-Market earnings guidance on Wednesday, February, 3rd. The company provided EPS guidance of 1.41-1.41 for the period. The company issued revenue guidance of $2.967-2.967 billion.

Who are Sysmex's key executives?

Sysmex's management team includes the following people:
  • Mr. Hisashi Ietsugu, Chairman of the Managing Board & CEO (Age 72) (LinkedIn Profile)
  • Mr. Yukio Nakajima, Sr. Exec. Officer, Sr. MD of Corp. Bus. Planning & Admin., CFO & Member of Managing Board (Age 71)
  • Mr. Kaoru Asano, CTO, COO LS Bus. Unit, Sr. MD, Sr. Exec. Officer & Member of the Managing Board (Age 63)
  • Tomoo Aramaki, Exec. VP of Corp. Bus. Admin.
  • Mr. Yukio Hamaguchi, Sr. Exec. Officer & Exec. VP of Reagent Production
  • Mr. Junzo Yamamoto, Sr. Exec. Officer, MD of Manufacturing & SCM and Member of the Managing Board (Age 66)
  • Mr. Iwane Matsui, Sr. Exec. Officer, MD of Global Bus. & Member of the Managing Board (Age 60)
  • Mr. Kenji Tachibana, Sr. Exec. Officer, Sr. MD, COO IVD Bus. Unit & Member of the Managing Board (Age 64) (LinkedIn Profile)
  • Mr. Ikuo Otani, Sr. Exec. Officer of IVD Bus. Unit & IVD Product Devel.
  • Mr. Hiroshi Kanda, Sr. Exec. Officer, MD of IVD Bus. Unit & IVD Bus. Devel. & Member of Managing Board (Age 64)

Who are some of Sysmex's key competitors?

Some companies that are related to Sysmex include Schneider Electric S.E. (SBGSY), Recruit (RCRRF), Iberdrola (IBDRY), KDDI (KDDIY), Atlas Copco (ATLKY), L'Air Liquide (AIQUY), Shin-Etsu Chemical (SHECY), Vinci (VCISY), Deutsche Post (DPSGY), Daikin Industries,Ltd. (DKILY), Oriental Land (OLCLY), Pjsc Lukoil (LUKOY), Bayerische Motoren Werke Aktiengesellschaft (BAMXF), DENSO (DNZOY) and Sun Hung Kai Properties (SUHJY).
View all of SSMXY's competitors.

What is Sysmex's stock symbol?

Sysmex trades on the OTCMKTS under the ticker symbol "SSMXY."

How do I buy shares of Sysmex?

Shares of SSMXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sysmex's stock price today?

One share of SSMXY stock can currently be purchased for approximately $54.09.

How much money does Sysmex make?

Sysmex has a market capitalization of $22.58 billion and generates $2.78 billion in revenue each year. The company earns $320.91 million in net income (profit) each year or $0.77 on an earnings per share basis.

How many employees does Sysmex have?

Sysmex employs 8,200 workers across the globe.

Does Sysmex have any subsidiaries?

The following companies are subsidiares of Sysmex: HITADO GmbH, HYPHEN BioMed SAS, Jinan Sysmex Medical Electronics Co. Ltd., Medicaroid Corporation, PT.Sysmex Indonesia, RIKEN GENESIS CO. LTD., Sysmex (Malaysia) Sdn Bhd, Sysmex (Thailand) Co. Ltd., Sysmex America Inc., Sysmex Asia Pacific Pte Ltd., Sysmex Australia Pty Ltd., Sysmex Austria GmbH, Sysmex Belgium N.V., Sysmex Business Support Co. Ltd., Sysmex CNA Co. Ltd., Sysmex CZ s.r.o., Sysmex Canada Inc., Sysmex Colombia SAS, Sysmex Deutschland GmbH, Sysmex Diagnósticos México S. de R.L. de C.V., Sysmex Engineering Co. Ltd., Sysmex Espana S.L., Sysmex Europe GmbH, Sysmex France S.A.S., Sysmex Hong Kong Limited, Sysmex Hungaria Kft., Sysmex India Pvt. Ltd., Sysmex Inostics GmbH, Sysmex Inostics Inc., Sysmex International Reagents Co. Ltd., Sysmex Korea Co. Ltd., Sysmex Latin America & the Caribbean, Sysmex Medica Co. Ltd., Sysmex Middle East FZ - LLC, Sysmex Nederland B.V., Sysmex New Zealand Limited, Sysmex Nordic ApS, Sysmex Norge, Sysmex Partec GmbH, Sysmex Philippines Inc., Sysmex Polska Sp.z o.o., Sysmex RA Co. Ltd., Sysmex RUS LLC, Sysmex Reagents America Inc., Sysmex Shanghai Ltd., Sysmex Slovakia s.r.o., Sysmex South Africa (Pty) Ltd., Sysmex Suisse AG, Sysmex Sverige, Sysmex TAIWAN Co. Ltd., Sysmex TMC Co. Ltd., Sysmex Transasia Services Pvt Ltd., Sysmex Turkey Diagnostik Sistemleri Ltd. Sti., Sysmex UK Limited, Sysmex Vietnam Company Limited, Sysmex West and Central Africa Ltd., Sysmex Wuxi Co. Ltd., Sysmex bioMérieux Co. Ltd., and Sysmex do Brasil Indústria e Comércio Ltda..

When was Sysmex founded?

Sysmex was founded in 1968.

What is Sysmex's official website?

The official website for Sysmex is www.sysmex.co.jp.

Where are Sysmex's headquarters?

Sysmex is headquartered at 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073.

How can I contact Sysmex?

Sysmex's mailing address is 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073. The company can be reached via phone at 817-8265-0500.


This page was last updated on 2/26/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.